TransMedics Group, Inc. (TMDX)
67.20
-0.63
(-0.93%)
USD |
NASDAQ |
May 29, 16:00
67.29
+0.09
(+0.13%)
After-Hours: 20:00
TransMedics Group Free Cash Flow : 151.36M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 7.378B |
| DexCom, Inc. | 1.429B |
| Integer Holdings Corp. | 99.80M |
| Globus Medical, Inc. | 605.57M |
| GlucoTrack, Inc. | -16.44M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 24.53M |
| Cash from Investing (Quarterly) | -36.66M |
| Cash from Financing (Quarterly) | 3.762M |
| Free Cash Flow Per Share (Quarterly) | -0.335 |
| Free Cash Flow to Equity (Quarterly) | -356.26M |
| Free Cash Flow to Firm (Quarterly) | -5.943M |
| Free Cash Flow Yield | 5.69% |